Thermo Fisher Completes Acquisition of Finesse Solutions
Thermo Fisher Scientific today completed its previously announced acquisition of Finesse Solutions, a developmer of scalable control automation systems and software for bioproduction. The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. Terms of the transaction were not disclosed.
Based in Santa Clara, California, Finesse Solutions is a bioprocess management technology, generating approximately $50 million in revenue in 2016. Its proprietary Smart™ technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow. The company has been a technology partner of Thermo Fisher Scientific since 2013.
This article has been republished from materials provided by Thermo Fisher. Note: material may have been edited for length and content. For further information, please contact the cited source.
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Sharpest Image of Alzheimer’s Fibrils Shows Previously Unknown DetailsNews
The fibrils of the body's own amyloid beta (Aβ) protein are the main constituent of Alzheimer's disease-related and characteristic pathological protein deposits in the brain.READ MORE